PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 22, Issue 4, 2010, Pages 1181-1187

  Martínez García, Ana ^a,b   Sastre, Isabel ^a,b   Recuero, María ^a,b   Aldudo, Jesús ^a,b   Vilella, Elisabet ^c   Mateo, Ignacio ^b,d   Sánchez Juan, Pascual ^b,d   Vargas, Teo ^b,e   Carro, Eva ^b,e   Bermejo Pareja, Félix ^b,e   Rodríguez Rodríguez, Eloy ^b,d   Combarros, Onofre ^b,d   Rosich Estrago, Marcel ^c   Frank, Ana ^b,f   Valdivieso, Fernando ^a,b   Bullido, María J ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c IISPV   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Alzheimer's disease; cell injury; genetic association; neurodegeneration; oxidative stress; PLA2G3

Indexed keywords

ADENOVIRUS VECTOR; PHOSPHOLIPASE A2 GROUP III; SHORT HAIRPIN RNA; XANTHINE OXIDASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CELL DEATH; CELL STRAIN HEK293; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NERVE CELL LESION; NEUROMODULATION; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

EID: 79751507068     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101348     Document Type: Article

References (27)

1. Lendon CL, Ashall F, Goate AM (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277, 825-831. (Pubitemid 27111320)
2. Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA (2007) Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. J Pharmacol Exp Ther 321, 823-829. (Pubitemid 46762675)
3. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314, 777-781. (Pubitemid 44706636)
4. Yankner BA, Lu T, Loerch P (2008) The aging brain. Annu Rev Pathol 3, 41-66. (Pubitemid 351488276)
5. Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Ox-idative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt TechnolBiomed Life Sci 827, 65-75. (Pubitemid 41551598)
6. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10(Suppl), S18-25. (Pubitemid 38901863)
7. Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G (2005) Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J Neural Transm 112, 921-932. (Pubitemid 40869081)
8. Recuero M, Vicente MC, Martinez-Garcia A, Ramos MC, Carmona-Saez P, Sastre I, Aldudo J, Vilella E, Frank A, Bullido MJ, Valdivieso F (2009) A free radical-generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease. Aging Cell 8, 128-139.
9. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G (2000) Novel human secreted phospholipase A(2) with ho-mology to the group III bee venom enzyme. J Biol Chem 275, 7492-7496. (Pubitemid 30159644)
10. DeCoster MA (2003) Group III secreted phospholipase A2 causes apoptosis in rat primary cortical neuronal cultures. Brain Res 988, 20-28.
11. Masuda S, Yamamoto K, Hirabayashi T, Ishikawa Y, Ishii T, Kudo I, Murakami M (2008) Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival. Biochem J 409, 429-438. (Pubitemid 351184961)
12. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007)Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
13. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114, 4557-4565. (Pubitemid 34086890)
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
15. Wilson HS, Skodol A (1994) Special report: DSM-IV: overview and examination of major changes. Arch Psychiatr Nurs 8, 340-347.
16. Bullido MJ, Martinez-Garcia A, Artiga MJ, Aldudo J, Sastre I, Gil P, Coria F, Munoz DG, Hachinski V, Frank A, Valdivieso F (2007) A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. Neurobiol Aging 28, 519-523. (Pubitemid 46282206)
17. Vargas T, Bullido MJ, Martinez-Garcia A, Antequera D, Clarimon J, Rosich-Estrago M, Martin-Requero A, Mateo I, Rodriguez-Rodriguez E, Vilella-Cuadrada E, Frank A, Lleo A, Molina-Porcel L, Blesa R, Combarros O, Gomez-Isla T, Bermejo-Pareja F, Valdivieso F, Carro E A megalin polymorphism associated with promoter activity and Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet 153B, 895-902.
18. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437, 1299-1320.
19. International HapMap Consortium (2003) The International HapMap Project. Nature 426, 789-796.
20. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinfor-matics 21, 263-265. (Pubitemid 40202029)
21. Pratico D (2008) Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147, 70-78.
22. Zawia NH, Lahiri DK, Cardozo-Pelaez F (2009) Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 46, 1241-1249.
23. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 1094-1099.
24. Zhao M, Brunk UT, Eaton JW (2001) Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 509, 399-404. (Pubitemid 34031968)
25. Farooqui AA, Ong WY, Horrocks LA (2004) Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem Res 29, 1961-1977. (Pubitemid 40003755)
26. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B, Cisse M, Scearce-Levie K, Cheng IH, Gan L, Palop JJ, Bonventre JV, Mucke L (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11, 1311-1318.
27. Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36, D820-824. (Pubitemid 351149829)